Summit Therapeutics (SMMT) Cash flow

1 Followers

Summit Therapeutics Cash Flow

MX:SMMT's free cash flow for Q2 2026 was £-168.75M. For the 2026 fiscal year, MX:SMMT's free cash flow was decreased by £-126.49M and operating cash flow was £-167.78M. See a summary of the company’s cash flow.

Cash Flow	Dec 25	Dec 24	Dec 23	Dec 22	Dec 21
Operating Cash Flow	$ -239.67M	$ -113.56M	$ -60.74M	$ -33.90M	$ -53.81M
Investing Cash Flow	$ -129.37M	$ -164.09M	$ -465.14M	$ -508.68K	$ -226.83K
Financing Cash Flow	$ 458.31M	$ 304.63M	$ 68.46M	$ 505.62M	$ 57.76M
End Cash Position	$ 167.42M	$ 84.05M	$ 56.52M	$ 528.74M	$ 53.22M
Free Cash Flow	$ -240.15M	$ -113.67M	$ -60.85M	$ -34.41M	$ -54.03M